CD8A and infection: Others have proposed monitoring of CD8+ CMV‐STs as a prognostic tool to identify allo‐HCT patients at high risk for CMV‐infections [52, 57], however, by evaluating only CD8+ cells, and given the importance of CD4+ STs in controlling infections [58], the clinical response may be misinterpreted or/and underestimated.